The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
Open accessAbstract
Data on human papillomavirus (HPV) type distribution in invasive and pre‐invasive cervical cancer is essential to predict the future impact of HPV16/18 vaccines and HPV‐based screening tests. A meta‐analyses of HPV type distribution in invasive cervical cancer (ICC) and high‐grade squamous intraepithelial lesions (HSIL) identified a total of 14,595 and 7,094 cases, respectively. In ICC, HPV16 was the most common, and HPV18 the second most common, type in all continents. Combined HPV16/18 prevalence among ICC cases was slightly higher in Europe, North America and Australia (74–77%) than in Africa, Asia and South/Central America (65–70%). The next most common HPV types were the same in each continent, namely HPV31, 33, 35, 45, 52 and 58, although their relative importance differed somewhat by region. HPV18 was significantly more prevalent in adeno/adenosquamous carcinoma than in squamous cell carcinoma, with the reverse being true for HPV16, 31, 33, 52 and 58. Among HSIL cases, HPV16/18 prevalence was 52%. However, HPV 16, 18 and 45 were significantly under‐represented, and other high‐risk HPV types significantly over‐represented in HSIL compared to ICC, suggesting differences in type‐specific risks for progression. Data on HPV‐typed ICC and HSIL cases were particularly scarce from large regions of Africa and Central Asia. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Self-citationMuñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G. M., Smith, J. S., Aguado, T., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601024 · Cited by 684
Self-citationClifford, G. M., Rana, R. K., Franceschi, S., Smith, J. S., Gough, G., & Pimenta, J. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0812 · Cited by 533
Self-citationChapter 12: Human Papillomavirus Technologies
Iftner, T., & Villa, L. L. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003487 · Cited by 209
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia
Woodman, C. B. J., Collins, S. I., Rollason, T. P., Winter, H., Bailey, A. C., Yates, M., & Young, L. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12120-4 · Cited by 75
Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests
Franceschi, S., & Clifford, G. M. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji159 · Cited by 37
Self-citation
Cited by
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728
Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N., Apter, D. L., Kitchener, H. C., Castellsague, X., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60946-5 · Cited by 1,315
Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,066
Self-citationDe Vuyst, H., Clifford, G. M., Nascimento, M. C., Madeleine, M. M., & Franceschi, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24116 · Cited by 966
Self-citationGuan, P., Howell‐Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., & Clifford, G. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27485 · Cited by 927
Self-citationNooraei, S., Bahrulolum, H., Hoseini, Z. S., Katalani, C., Hajizade, A., Easton, A. J., & Ahmadian, G. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00806-7 · Cited by 869
Bosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Arbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 760
Human Papillomavirus Testing in the Prevention of Cervical Cancer
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq562 · Cited by 759
Meijer, C. J. L. M., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24010 · Cited by 692
Brown, D. R., Kjaer, S. K., Sigurdsson, K., Iversen, O., Hernandez‐Avila, M., Wheeler, C. M., Perez, G., Koutsky, L. A., Tay, E. H., Garcia, P., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597307 · Cited by 627
Brotherton, J. M., Fridman, M., May, C. L., Chappell, G., Saville, A. M., & Gertig, D. M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60551-5 · Cited by 598
Natural history and epidemiology of HPV infection and cervical cancer
Castellsagué, X. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.07.045 · Cited by 590
Human papillomavirus genome variants
Burk, R. D., Harari, A., & Chen, Z. (2013) · Virology · doi:10.1016/j.virol.2013.07.018 · Cited by 484
Pathology and epidemiology of HPV infection in females
Stanley, M. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.024 · Cited by 470
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions
Hoots, B. E., Palefsky, J. M., Pimenta, J. M., & Smith, J. S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24215 · Cited by 461
Self-citationSchiffman, M., Clifford, G., & Buonaguro, F. M. (2009) · Infectious Agents and Cancer · doi:10.1186/1750-9378-4-8 · Cited by 448
Self-citationKoshiol, J., Lindsay, L., Pimenta, J. M., Poole, C., Jenkins, D., & Smith, J. S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn036 · Cited by 428
Self-citationThe human papillomavirus family and its role in carcinogenesis
Tommasino, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.002 · Cited by 411
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Edwards, R. P., Zepp, F., Carletti, I., Dessy, F. J., Trofa, A. F., Schuind, A., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9518 · Cited by 402
Syrjänen, S., Lodi, G., von Bültzingslöwen, I., Aliko, A., Arduino, P., Campisi, G., Challacombe, S., Ficarra, G., Flaitz, C., Zhou, H., et al. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01792.x · Cited by 378
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
Smith, J. S., Melendy, A., Rana, R. K., & Pimenta, J. M. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.07.009 · Cited by 377
Self-citationWelters, M. J. P., Kenter, G. G., Piersma, S. J., Vloon, A. P. G., Löwik, M. J. G., Berends-van der Meer, D. M. A., Drijfhout, J. W., Valentijn, A. R. P. M., Wafelman, A. R., Oostendorp, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1880 · Cited by 373
Human papillomavirus and HPV vaccines: a review
Cutts, F. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038414 · Cited by 370
Applications of gold nanoparticles in virus detection
Draz, M. S., & Shafiee, H. (2018) · Theranostics · doi:10.7150/thno.23856 · Cited by 342
The biological properties of E6 and E7 oncoproteins from human papillomaviruses
Ghittoni, R., Accardi, R., Hasan, U., Gheit, T., Sylla, B., & Tommasino, M. (2010) · Virus Genes · doi:10.1007/s11262-009-0412-8 · Cited by 322
Parents' health beliefs and HPV vaccination of their adolescent daughters
Reiter, P. L., Brewer, N. T., Gottlieb, S. L., McRee, A.-L., & Smith, J. S. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.05.024 · Cited by 319
Self-citationRisk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer
Chelimo, C., Wouldes, T. A., Cameron, L. D., & Elwood, J. M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2012.10.024 · Cited by 303
Tabrizi, S. N., Brotherton, J. M. L., Kaldor, J. M., Skinner, S. R., Liu, B., Bateson, D., McNamee, K., Garefalakis, M., Phillips, S., Cummins, E., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70841-2 · Cited by 301
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Serrano, B., Alemany, L., Tous, S., Bruni, L., Clifford, G. M., Weiss, T., Bosch, F. X., & de Sanjosé, S. (2012) · Infectious Agents and Cancer · doi:10.1186/1750-9378-7-38 · Cited by 301
Self-citationLu, B., Kumar, A., Castellsagué, X., & Giuliano, A. R. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-13 · Cited by 283
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
Gertig, D. M., Brotherton, J. M., Budd, A. C., Drennan, K., Chappell, G., & Saville, A. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-227 · Cited by 277
The ATHENA human papillomavirus study: design, methods, and baseline results
Wright, T. C., Stoler, M. H., Behrens, C. M., Apple, R., Derion, T., & Wright, T. L. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.024 · Cited by 275
Human Papillomavirus Type-Distribution in Vulvar and Vaginal Cancers and Their Associated Precursors
Smith, J. S., Backes, D. M., Hoots, B. E., Kurman, R. J., & Pimenta, J. M. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31819bd6e0 · Cited by 273
Self-citationInsinga, R. P., Liaw, K.-L., Johnson, L. G., & Madeleine, M. M. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2922 · Cited by 267
Cervical Cancer Prevention—Cervical Screening: Science in Evolution
Safaeian, M., Solomon, D., & Castle, P. E. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.09.004 · Cited by 265
Key Molecular Events in Cervical Cancer Development
Balasubramaniam, S. D., Balakrishnan, V., Oon, C. E., & Kaur, G. (2019) · Medicina · doi:10.3390/medicina55070384 · Cited by 263
Chrysostomou, A. C., Stylianou, D. C., Constantinidou, A., & Kostrikis, L. G. (2018) · Viruses · doi:10.3390/v10120729 · Cited by 258
Infections and cancer: Established associations and new hypotheses
de Martel, C., & Franceschi, S. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.07.021 · Cited by 258
Self-citationMitra, A., MacIntyre, D. A., Ntritsos, G., Smith, A., Tsilidis, K. K., Marchesi, J. R., Bennett, P. R., Moscicki, A.-B., & Kyrgiou, M. (2020) · Nature Communications · doi:10.1038/s41467-020-15856-y · Cited by 257
Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A.-L., Liddon, N., Markowitz, L., & Smith, J. S. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181f12dbf · Cited by 254
Self-citationHealth and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
Goldie, S. J., O'Shea, M., Campos, N. G., Diaz, M., Sweet, S., & Kim, S.-Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.053 · Cited by 197
Sankaranarayanan, R., Joshi, S., Muwonge, R., Esmy, P. O., Basu, P., Prabhu, P., Bhatla, N., Nene, B. M., Shaw, J., Poli, U. R. R., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.087 · Cited by 164
Lazarczyk, M., Cassonnet, P., Pons, C., Jacob, Y., & Favre, M. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-08 · Cited by 131
Human Papillomavirus L2 Facilitates Viral Escape from Late Endosomes via Sorting Nexin 17
Bergant Marušič, M., Ozbun, M. A., Campos, S. K., Myers, M. P., & Banks, L. (2012) · Traffic · doi:10.1111/j.1600-0854.2011.01320.x · Cited by 130
The impact of cervical cancer on quality of life—The components and means for management
Herzog, T. J., & Wright, J. D. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.09.019 · Cited by 119
Global Proficiency Study of Human Papillomavirus Genotyping
Eklund, C., Zhou, T., & Dillner, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00918-10 · Cited by 122
An updated natural history model of cervical cancer: derivation of model parameters
Campos, N. G., Burger, E. A., Sy, S., Sharma, M., Schiffman, M., Rodriguez, A. C., Hildesheim, A., Herrero, R., & Kim, J. J. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu159 · Cited by 116
Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV Types
Herrero, R. (2009) · The Journal of Infectious Diseases · doi:10.1086/597308 · Cited by 104
Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997–2012
Baldur-Felskov, B., Munk, C., Nielsen, T. S. S., Dehlendorff, C., Kirschner, B., Junge, J., & Kjaer, S. K. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0603-7 · Cited by 76
(2009) · PubMed · Cited by 70
Prevalence of human papillomavirus types in cervical and oral cancers in central India
Gheit, T., Vaccarella, S., Schmitt, M., Pawlita, M., Franceschi, S., Sankaranarayanan, R., Sylla, B. S., Tommasino, M., & Gangane, N. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.11.041 · Cited by 68
Self-citationHuman Papillomavirus-Type Distribution in Women With and Without Cervical Neoplasia in North India
Bhatla, N., Dar, L., Rajkumar Patro, A., Kumar, P., Pati, S. K., Kriplani, A., Gulati, A., Broor, S., Iyer, V. K., Mathur, S., et al. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31816085ba · Cited by 54
HPV genotype distribution according to severity of cervical neoplasia
Sjoeborg, K. D., Tropé, A., Lie, A. K., Jonassen, C. M., Steinbakk, M., Hansen, M., Jacobsen, M. B., Cuschieri, K., & Eskild, A. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.03.007 · Cited by 54
Park, Y., Lee, E., Choi, J., Jeong, S., & Kim, H.-S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00337-12 · Cited by 51
Baloch, Z., Li, Y., Yuan, T., Feng, Y., Liu, Y., Tai, W., Liu, L., Wang, B., Zhang, A.-M., Wu, X., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1562-7 · Cited by 42
Prevalence of human papillomavirus types in cervical lesions from women in rural Western India
Deodhar, K., Gheit, T., Vaccarella, S., Romao, C. C., Tenet, V., Nene, B. M., Jayant, K., Kelkar, R., Malvi, S. G., Sylla, B. S., et al. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23310 · Cited by 34
Self-citationResende, L. S. D. A., Rabelo-Santos, S. H., Sarian, L. O., Alves, R. R. F., Ribeiro, A. A., Zeferino, L. C., & Derchain, S. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-214 · Cited by 23
Mahomed, K., Evans, D., Sauls, C., Richter, K., Smith, J., & Firnhaber, C. (2014) · Pan African Medical Journal · doi:10.11604/pamj.2014.17.189.3454 · Cited by 23
“In a study amongst women with ICC (167 in Ghana, 192 in Nigeria and 300 in South Africa), HPV-positivity rate in ICC cases was 90% (515/570) with HPV16 (51%), HPV18 (17%), HPV35 (9%), HPV45 (7%), HPV33 (4”
BackgroundSelf-citationWong, E. L. Y., Cheung, A. W. L., Huang, F., & Chor, J. S. Y. (2018) · Cancer Nursing · doi:10.1097/ncc.0000000000000462 · Cited by 19
Munjal, K., Adamson, C. S.-C., Rajendran, V., Nandedkar, S., Cooper, K., & Evans, M. F. (2014) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000083 · Cited by 18
Broquet, C., Vassilakos, P., Ndam Nsangou, F. M., Kenfack, B., Noubom, M., Tincho, E., Jeannot, E., Wisniak, A., & Petignat, P. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057234 · Cited by 17
Mafi, S., Theuillon, F., Meyer, S., Woillard, J.-B., Dupont, M., Rogez, S., Alain, S., & Hantz, S. (2025) · PLOS ONE · doi:10.1371/journal.pone.0320978 · Cited by 10
“HPV16 and 18 are responsible for at least 70% of cervical cancers [5,6].”
See-and-Treat Approaches to Cervical Cancer Prevention for HIV-Infected Women
Chibwesha, C. J., & Cu-Uvin, S. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0084-6 · Cited by 9
Metadata
- Authors
- Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-05-25
- Volume
- 121
- Issue
- 3
- Pages
- 621-632
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2047580791
- Cited by
- 1,686
- References
- 10
- FWCI
- 85.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.